Consistent with this notion, no significant relationships were apparent between concentrations of SCFA in patient stool and clinical markers of obesity measured at enrollment, including BMI, insulin levels, and HbA1c (Table 2), although this may also be explained by uncontrolled patient parameters. The gene discussed is INS; the disease is obesity disorder.